drugset / Trial / NCT00003938

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

NCT00003938

RandomizedSupportive care

Summary

RATIONALE: Liposomal amphotericin B may be effective in controlling fever and granulocytopenia. It is not yet known which regimen of liposomal amphotericin B is more effective in treating cancer patients who have these conditions. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of liposomal amphotericin B in treating granulocytopenia and fever in cancer patients.

Timeline

Start
1999-06
Primary completion
2003-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown Intravenous

Indications